128 related articles for article (PubMed ID: 9576121)
1. Kallikrein gene delivery attenuates hypertension and cardiac hypertrophy and enhances renal function in Goldblatt hypertensive rats.
Yayama K; Wang C; Chao L; Chao J
Hypertension; 1998 May; 31(5):1104-10. PubMed ID: 9576121
[TBL] [Abstract][Full Text] [Related]
2. Human kallikrein gene delivery attenuates hypertension, cardiac hypertrophy, and renal injury in Dahl salt-sensitive rats.
Chao J; Zhang JJ; Lin KF; Chao L
Hum Gene Ther; 1998 Jan; 9(1):21-31. PubMed ID: 9458239
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy in hypertension: adenovirus-mediated kallikrein gene delivery in hypertensive rats.
Jin L; Zhang JJ; Chao L; Chao J
Hum Gene Ther; 1997 Oct; 8(15):1753-61. PubMed ID: 9358025
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus-mediated kallikrein gene delivery reverses salt-induced renal injury in Dahl salt-sensitive rats.
Chao J; Zhang JJ; Lin KF; Chao L
Kidney Int; 1998 Oct; 54(4):1250-60. PubMed ID: 9767541
[TBL] [Abstract][Full Text] [Related]
5. Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure.
Wolf WC; Yoshida H; Agata J; Chao L; Chao J
Kidney Int; 2000 Aug; 58(2):730-9. PubMed ID: 10916096
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated kallikrein gene delivery attenuates hypertension and protects against renal injury in deoxycorticosterone-salt rats.
Dobrzynski E; Yoshida H; Chao J; Chao L
Immunopharmacology; 1999 Oct; 44(1-2):57-65. PubMed ID: 10604525
[TBL] [Abstract][Full Text] [Related]
7. Human kallikrein gene delivery protects against gentamycin-induced nephrotoxicity in rats.
Murakami H; Yayama K; Chao L; Chao J
Kidney Int; 1998 May; 53(5):1305-13. PubMed ID: 9573546
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus-mediated kallikrein gene delivery reduces aortic thickening and stroke-induced death rate in Dahl salt-sensitive rats.
Zhang JJ; Chao L; Chao J
Stroke; 1999 Sep; 30(9):1925-31; discussion 1931-2. PubMed ID: 10471446
[TBL] [Abstract][Full Text] [Related]
9. Experimental kallikrein gene therapy in hypertension, cardiovascular and renal diseases.
Chao J; Chao L
Pharmacol Res; 1997 Jun; 35(6):517-22. PubMed ID: 9356201
[TBL] [Abstract][Full Text] [Related]
10. Adrenomedullin gene delivery attenuates renal damage and cardiac hypertrophy in Goldblatt hypertensive rats.
Wang C; Dobrzynski E; Chao J; Chao L
Am J Physiol Renal Physiol; 2001 Jun; 280(6):F964-71. PubMed ID: 11352835
[TBL] [Abstract][Full Text] [Related]
11. Human adrenomedullin gene delivery protects against cardiac hypertrophy, fibrosis, and renal damage in hypertensive dahl salt-sensitive rats.
Zhang JJ; Yoshida H; Chao L; Chao J
Hum Gene Ther; 2000 Sep; 11(13):1817-27. PubMed ID: 10986555
[TBL] [Abstract][Full Text] [Related]
12. Human tissue kallikrein attenuates hypertension and secretes into circulation and urine after intramuscular gene delivery in hypertensive rats.
Zhang JJ; Wang C; Lin KF; Chao L; Chao J
Clin Exp Hypertens; 1999 Oct; 21(7):1145-60. PubMed ID: 10513833
[TBL] [Abstract][Full Text] [Related]
13. Kallikrein gene therapy: a new strategy for hypertensive diseases.
Chao J; Chao L
Immunopharmacology; 1997 Jun; 36(2-3):229-36. PubMed ID: 9228551
[TBL] [Abstract][Full Text] [Related]
14. Adrenomedullin gene delivery attenuates hypertension, cardiac remodeling, and renal injury in deoxycorticosterone acetate-salt hypertensive rats.
Dobrzynski E; Wang C; Chao J; Chao L
Hypertension; 2000 Dec; 36(6):995-1001. PubMed ID: 11116114
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus-mediated human tissue kallikrein gene delivery inhibits neointima formation induced by interruption of blood flow in mice.
Emanueli C; Salis MB; Chao J; Chao L; Agata J; Lin KF; Munaò A; Straino S; Minasi A; Capogrossi MC; Madeddu P
Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1459-66. PubMed ID: 10845858
[TBL] [Abstract][Full Text] [Related]
16. Kallikrein gene delivery improves cardiac reserve and attenuates remodeling after myocardial infarction.
Agata J; Chao L; Chao J
Hypertension; 2002 Nov; 40(5):653-9. PubMed ID: 12411458
[TBL] [Abstract][Full Text] [Related]
17. Kallikrein gene transfer reduces renal fibrosis, hypertrophy, and proliferation in DOCA-salt hypertensive rats.
Xia CF; Bledsoe G; Chao L; Chao J
Am J Physiol Renal Physiol; 2005 Sep; 289(3):F622-31. PubMed ID: 15886273
[TBL] [Abstract][Full Text] [Related]
18. Central delivery of human tissue kallikrein gene reduces blood pressure in hypertensive rats.
Wang C; Chao C; Madeddu P; Chao L; Chao J
Biochem Biophys Res Commun; 1998 Mar; 244(2):449-54. PubMed ID: 9514899
[TBL] [Abstract][Full Text] [Related]
19. Kallikrein gene delivery attenuates cardiac remodeling and promotes neovascularization in spontaneously hypertensive rats.
Bledsoe G; Chao L; Chao J
Am J Physiol Heart Circ Physiol; 2003 Oct; 285(4):H1479-88. PubMed ID: 12816755
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus-mediated kallikrein gene transfer inhibits neointima formation via increased production of nitric oxide in rat artery.
Murakami H; Miao RQ; Chao L; Chao J
Immunopharmacology; 1999 Oct; 44(1-2):137-43. PubMed ID: 10604537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
